Loading…
Heparin-induced thrombocytopenia and the use of r-hirudin during cardiopulmonary bypass
We report the successful use of r-hirudin (lepirudin) for cardiopulmonary bypass in a 67-year-old man who developed heparin-induced thrombocytopenia type II during heparin treatment of an extensive deep venous thrombosis. Lepirudin was monitored by the modified ecarin clotting time in a "mobile...
Saved in:
Published in: | Anaesthesia and intensive care 2005-06, Vol.33 (3), p.388-392 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c402t-1fc9f157d41a2b39d3c217d0a88bed4d1c648f5d557831b263a9b285d023e3433 |
---|---|
cites | cdi_FETCH-LOGICAL-c402t-1fc9f157d41a2b39d3c217d0a88bed4d1c648f5d557831b263a9b285d023e3433 |
container_end_page | 392 |
container_issue | 3 |
container_start_page | 388 |
container_title | Anaesthesia and intensive care |
container_volume | 33 |
creator | MANIKAPPA, S BENFIELD, K GAN, T. E BUTLER, J MALAN, E TRAN, H. A. M TUCKER, A |
description | We report the successful use of r-hirudin (lepirudin) for cardiopulmonary bypass in a 67-year-old man who developed heparin-induced thrombocytopenia type II during heparin treatment of an extensive deep venous thrombosis. Lepirudin was monitored by the modified ecarin clotting time in a "mobile laboratory" set up next to the cardiac theatre, aiming for lepirudin levels of 3.5 to 4.5 microg/ml during bypass. |
doi_str_mv | 10.1177/0310057x0503300316 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_224840718</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>879609371</sourcerecordid><originalsourceid>FETCH-LOGICAL-c402t-1fc9f157d41a2b39d3c217d0a88bed4d1c648f5d557831b263a9b285d023e3433</originalsourceid><addsrcrecordid>eNpFkE1LAzEQhoMotlb_gAcJgsfVfG6yRylqhYIXxd6WbJK1Kd3NmjRg_70pXehpmOF5Z4YHgFuMHjEW4glRjBAXf4gjSlHuyjMwxYzJAhGBz8H0ABSZWE3AVYwbhHBFBL8EE8wrQSvCpuB7YQcVXF-43iRtDdytg-8ar_c7P9jeKaj6w9DCFC30LQzF2oVkXA9NyrkfqFUwzg9p2_lehT1s9oOK8RpctGob7c1YZ-Dr9eVzviiWH2_v8-dloRkiuwK3umoxF4ZhRRpaGaoJFgYpKRtrmMG6ZLLlhnMhKW5ISVXVEMkNItRSRukM3B_3DsH_Jht39can0OeTNSFMMiSwzBA5Qjr4GINt6yG4Lj9bY1QfVNajytVJZQ7djZtT01lziozuMvAwAipqtW2D6rWLJ66UsmQVpf-1Y3uV</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>224840718</pqid></control><display><type>article</type><title>Heparin-induced thrombocytopenia and the use of r-hirudin during cardiopulmonary bypass</title><source>Sage Journals Online</source><source>Alma/SFX Local Collection</source><creator>MANIKAPPA, S ; BENFIELD, K ; GAN, T. E ; BUTLER, J ; MALAN, E ; TRAN, H. A. M ; TUCKER, A</creator><creatorcontrib>MANIKAPPA, S ; BENFIELD, K ; GAN, T. E ; BUTLER, J ; MALAN, E ; TRAN, H. A. M ; TUCKER, A</creatorcontrib><description>We report the successful use of r-hirudin (lepirudin) for cardiopulmonary bypass in a 67-year-old man who developed heparin-induced thrombocytopenia type II during heparin treatment of an extensive deep venous thrombosis. Lepirudin was monitored by the modified ecarin clotting time in a "mobile laboratory" set up next to the cardiac theatre, aiming for lepirudin levels of 3.5 to 4.5 microg/ml during bypass.</description><identifier>ISSN: 0310-057X</identifier><identifier>EISSN: 1448-0271</identifier><identifier>DOI: 10.1177/0310057x0503300316</identifier><identifier>PMID: 15973924</identifier><identifier>CODEN: AINCBS</identifier><language>eng</language><publisher>Edgecliff: Anaesthesia and Intensive Care</publisher><subject>Aged ; Anesthesia ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Cardiopulmonary Bypass ; Heparin - adverse effects ; Hirudin Therapy ; Humans ; Male ; Medical sciences ; Monitoring, Intraoperative - methods ; Thrombocytopenia - chemically induced ; Thrombocytopenia - classification ; Venous Thrombosis - drug therapy</subject><ispartof>Anaesthesia and intensive care, 2005-06, Vol.33 (3), p.388-392</ispartof><rights>2005 INIST-CNRS</rights><rights>Copyright Australian Society of Anaesthetists Jun 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c402t-1fc9f157d41a2b39d3c217d0a88bed4d1c648f5d557831b263a9b285d023e3433</citedby><cites>FETCH-LOGICAL-c402t-1fc9f157d41a2b39d3c217d0a88bed4d1c648f5d557831b263a9b285d023e3433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16886493$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15973924$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MANIKAPPA, S</creatorcontrib><creatorcontrib>BENFIELD, K</creatorcontrib><creatorcontrib>GAN, T. E</creatorcontrib><creatorcontrib>BUTLER, J</creatorcontrib><creatorcontrib>MALAN, E</creatorcontrib><creatorcontrib>TRAN, H. A. M</creatorcontrib><creatorcontrib>TUCKER, A</creatorcontrib><title>Heparin-induced thrombocytopenia and the use of r-hirudin during cardiopulmonary bypass</title><title>Anaesthesia and intensive care</title><addtitle>Anaesth Intensive Care</addtitle><description>We report the successful use of r-hirudin (lepirudin) for cardiopulmonary bypass in a 67-year-old man who developed heparin-induced thrombocytopenia type II during heparin treatment of an extensive deep venous thrombosis. Lepirudin was monitored by the modified ecarin clotting time in a "mobile laboratory" set up next to the cardiac theatre, aiming for lepirudin levels of 3.5 to 4.5 microg/ml during bypass.</description><subject>Aged</subject><subject>Anesthesia</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Cardiopulmonary Bypass</subject><subject>Heparin - adverse effects</subject><subject>Hirudin Therapy</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Monitoring, Intraoperative - methods</subject><subject>Thrombocytopenia - chemically induced</subject><subject>Thrombocytopenia - classification</subject><subject>Venous Thrombosis - drug therapy</subject><issn>0310-057X</issn><issn>1448-0271</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNpFkE1LAzEQhoMotlb_gAcJgsfVfG6yRylqhYIXxd6WbJK1Kd3NmjRg_70pXehpmOF5Z4YHgFuMHjEW4glRjBAXf4gjSlHuyjMwxYzJAhGBz8H0ABSZWE3AVYwbhHBFBL8EE8wrQSvCpuB7YQcVXF-43iRtDdytg-8ar_c7P9jeKaj6w9DCFC30LQzF2oVkXA9NyrkfqFUwzg9p2_lehT1s9oOK8RpctGob7c1YZ-Dr9eVzviiWH2_v8-dloRkiuwK3umoxF4ZhRRpaGaoJFgYpKRtrmMG6ZLLlhnMhKW5ISVXVEMkNItRSRukM3B_3DsH_Jht39can0OeTNSFMMiSwzBA5Qjr4GINt6yG4Lj9bY1QfVNajytVJZQ7djZtT01lziozuMvAwAipqtW2D6rWLJ66UsmQVpf-1Y3uV</recordid><startdate>20050601</startdate><enddate>20050601</enddate><creator>MANIKAPPA, S</creator><creator>BENFIELD, K</creator><creator>GAN, T. E</creator><creator>BUTLER, J</creator><creator>MALAN, E</creator><creator>TRAN, H. A. M</creator><creator>TUCKER, A</creator><general>Anaesthesia and Intensive Care</general><general>Sage Publications Ltd</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AYAGU</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>20050601</creationdate><title>Heparin-induced thrombocytopenia and the use of r-hirudin during cardiopulmonary bypass</title><author>MANIKAPPA, S ; BENFIELD, K ; GAN, T. E ; BUTLER, J ; MALAN, E ; TRAN, H. A. M ; TUCKER, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c402t-1fc9f157d41a2b39d3c217d0a88bed4d1c648f5d557831b263a9b285d023e3433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Aged</topic><topic>Anesthesia</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Cardiopulmonary Bypass</topic><topic>Heparin - adverse effects</topic><topic>Hirudin Therapy</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Monitoring, Intraoperative - methods</topic><topic>Thrombocytopenia - chemically induced</topic><topic>Thrombocytopenia - classification</topic><topic>Venous Thrombosis - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MANIKAPPA, S</creatorcontrib><creatorcontrib>BENFIELD, K</creatorcontrib><creatorcontrib>GAN, T. E</creatorcontrib><creatorcontrib>BUTLER, J</creatorcontrib><creatorcontrib>MALAN, E</creatorcontrib><creatorcontrib>TRAN, H. A. M</creatorcontrib><creatorcontrib>TUCKER, A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Australia & New Zealand Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>Anaesthesia and intensive care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MANIKAPPA, S</au><au>BENFIELD, K</au><au>GAN, T. E</au><au>BUTLER, J</au><au>MALAN, E</au><au>TRAN, H. A. M</au><au>TUCKER, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Heparin-induced thrombocytopenia and the use of r-hirudin during cardiopulmonary bypass</atitle><jtitle>Anaesthesia and intensive care</jtitle><addtitle>Anaesth Intensive Care</addtitle><date>2005-06-01</date><risdate>2005</risdate><volume>33</volume><issue>3</issue><spage>388</spage><epage>392</epage><pages>388-392</pages><issn>0310-057X</issn><eissn>1448-0271</eissn><coden>AINCBS</coden><abstract>We report the successful use of r-hirudin (lepirudin) for cardiopulmonary bypass in a 67-year-old man who developed heparin-induced thrombocytopenia type II during heparin treatment of an extensive deep venous thrombosis. Lepirudin was monitored by the modified ecarin clotting time in a "mobile laboratory" set up next to the cardiac theatre, aiming for lepirudin levels of 3.5 to 4.5 microg/ml during bypass.</abstract><cop>Edgecliff</cop><pub>Anaesthesia and Intensive Care</pub><pmid>15973924</pmid><doi>10.1177/0310057x0503300316</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0310-057X |
ispartof | Anaesthesia and intensive care, 2005-06, Vol.33 (3), p.388-392 |
issn | 0310-057X 1448-0271 |
language | eng |
recordid | cdi_proquest_journals_224840718 |
source | Sage Journals Online; Alma/SFX Local Collection |
subjects | Aged Anesthesia Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Cardiopulmonary Bypass Heparin - adverse effects Hirudin Therapy Humans Male Medical sciences Monitoring, Intraoperative - methods Thrombocytopenia - chemically induced Thrombocytopenia - classification Venous Thrombosis - drug therapy |
title | Heparin-induced thrombocytopenia and the use of r-hirudin during cardiopulmonary bypass |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T20%3A18%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Heparin-induced%20thrombocytopenia%20and%20the%20use%20of%20r-hirudin%20during%20cardiopulmonary%20bypass&rft.jtitle=Anaesthesia%20and%20intensive%20care&rft.au=MANIKAPPA,%20S&rft.date=2005-06-01&rft.volume=33&rft.issue=3&rft.spage=388&rft.epage=392&rft.pages=388-392&rft.issn=0310-057X&rft.eissn=1448-0271&rft.coden=AINCBS&rft_id=info:doi/10.1177/0310057x0503300316&rft_dat=%3Cproquest_cross%3E879609371%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c402t-1fc9f157d41a2b39d3c217d0a88bed4d1c648f5d557831b263a9b285d023e3433%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=224840718&rft_id=info:pmid/15973924&rfr_iscdi=true |